Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448285) titled 'Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Biobizkaia Health Research Institute
Condition:
Chronic Pain
Intervention:
Biological: Platelet-rich Plasma Local injection
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: February 24, 2026
Target Sample Size: 86
Countries of Recruitment:
Spain
To know more, visit ht...